tiprankstipranks
Advertisement
Advertisement
VISEN Deepens Losses as It Secures China Approval and Prepares to Launch Long-Acting Growth Hormone
PremiumCompany AnnouncementsVISEN Deepens Losses as It Secures China Approval and Prepares to Launch Long-Acting Growth Hormone
3M ago
VISEN Pharmaceuticals Sets March Board Meeting to Approve 2025 Annual Results
Premium
Company Announcements
VISEN Pharmaceuticals Sets March Board Meeting to Approve 2025 Annual Results
4M ago
VISEN Wins China Approval for Once-Weekly Growth Hormone Drug SKYTROFA
Premium
Company Announcements
VISEN Wins China Approval for Once-Weekly Growth Hormone Drug SKYTROFA
5M ago
VISEN Pharmaceuticals Schedules Board Meeting for Interim Results Review
PremiumCompany AnnouncementsVISEN Pharmaceuticals Schedules Board Meeting for Interim Results Review
10M ago
VISEN Pharmaceuticals Announces AGM Results and Strategic Leadership Changes
Premium
Company Announcements
VISEN Pharmaceuticals Announces AGM Results and Strategic Leadership Changes
12M ago
VISEN Pharmaceuticals Announces Supplemental Notice for AGM with Key Resolutions
Premium
Company Announcements
VISEN Pharmaceuticals Announces Supplemental Notice for AGM with Key Resolutions
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100